Ex-Biotech Exec Agrees To Penalty For Deceiving Auditors
The U.S. Securities and Exchange Commission announced Thursday that the former business chief of Osiris Therapeutics Inc. has agreed to pay $40,000 to exit a case accusing him and other executives...To view the full article, register now.
Already a subscriber? Click here to view full article